Teleflex Incorporated (TFX)

Currency in USD
101.66
-1.35(-1.31%)
Real-time Data·
Trading near 52-week Low
TFX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
100.76101.66
52 wk Range
100.76185.94
Key Statistics
Prev. Close
103
Open
100.76
Day's Range
100.76-101.66
52 wk Range
100.76-185.94
Volume
9.2K
Average Volume (3m)
739.92K
1-Year Change
-44.2765%
Book Value / Share
86.48
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TFX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
131.29
Upside
+29.14%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Teleflex Incorporated News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Teleflex Incorporated Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated SWOT Analysis


Financial Resilience
Teleflex demonstrates adaptability amidst challenges, adjusting guidance while maintaining profitability through effective cost management and strategic initiatives
Market Dynamics
Explore Teleflex's navigation of complex market forces, from unexpected customer losses to promising growth in key segments like Intra-Aortic Balloon Pumps
Strategic Vision
Delve into Teleflex's growth strategy, combining organic expansion with strategic acquisitions to strengthen market position and drive innovation
Analyst Outlook
Price targets range from $210 to $285, reflecting varied optimism about Teleflex's future prospects and ability to overcome current headwinds
Read full SWOT analysis

Teleflex Incorporated Earnings Call Summary for Q2/2025

  • Q2 2025 revenue up 4.2% to $780.9M; adjusted EPS rose 9.1% to $3.73; stock stable at $120.09
  • Interventional segment grew 19.3%; company exploring separation into RemainCo and NewCo
  • Acquired BioTronic's Vascular Intervention business; expects >6% growth from 2026
  • 2025 guidance: 7.7-8.7% constant currency revenue growth; adjusted EPS $13.90-$14.30
  • CEO focused on unlocking shareholder value; positive outlook on interested parties for potential separation
Last Updated: 15/10/2025, 01:02
Read Full Transcript

Compare TFX to Peers and Sector

Metrics to compare
TFX
Peers
Sector
Relationship
P/E Ratio
−13.9x12.3x−0.6x
PEG Ratio
0.06−0.150.00
Price/Book
1.2x3.3x2.6x
Price / LTM Sales
1.4x2.6x3.4x
Upside (Analyst Target)
26.2%67.0%41.5%
Fair Value Upside
Unlock11.6%5.5%Unlock

Analyst Ratings

1 Buy
10 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 131.29
(+29.14% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Hold115.00+11.65%130.00MaintainJan 20, 2026
Truist Securities
Hold135.00+31.07%120.00MaintainDec 18, 2025
RBC Capital
Hold135.00+31.07%120.00MaintainDec 17, 2025
Wells Fargo
Hold139.00+34.95%114.00MaintainDec 10, 2025
Citizens
Hold---MaintainDec 10, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -7.26%
Dividend Yield
1.32%
Industry Median 1.41%
Annualised payout
1.36
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
3.67 / 3.38
Revenue / Forecast
913.00M / 892.75M
EPS Revisions
Last 90 days

TFX Income Statement

People Also Watch

20.11
BAX
-1.28%
191.40
MOH
-1.21%
65.96
FISV
-0.51%
57.89
ARE
+1.10%
224.96
WDC
+1.56%

FAQ

What Is the Teleflex (TFX) Premarket Price Today?

The Teleflex (TFX) premarket price is 102.50. Premarket price change units: -0.50. Premarket percentage change: -0.49%. Premarket volume: 1,690.00. Current date: 20 Jan 2026. Previous close: 103.00

What Stock Exchange Does Teleflex Trade On?

Teleflex is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Teleflex?

The stock symbol for Teleflex is "TFX."

What Is the Teleflex Market Cap?

As of today, Teleflex market cap is 4.55B.

What Is Teleflex's Earnings Per Share (TTM)?

The Teleflex EPS (TTM) is -7.26.

When Is the Next Teleflex Earnings Date?

Teleflex will release its next earnings report on 18 Feb 2026.

From a Technical Analysis Perspective, Is TFX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Teleflex Stock Split?

Teleflex has split 12 times.

How Many Employees Does Teleflex Have?

Teleflex has 14100 employees.

What is the current trading status of Teleflex (TFX)?

As of 20 Jan 2026, Teleflex (TFX) is trading at a price of 101.66, with a previous close of 103.00. The stock has fluctuated within a day range of 100.76 to 101.66, while its 52-week range spans from 100.76 to 185.94.

What Is Teleflex (TFX) Price Target According to Analysts?

The average 12-month price target for Teleflex is USD131.29, with a high estimate of USD155 and a low estimate of USD115. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +29.14% Upside potential.

What Is the TFX Premarket Price?

TFX's last pre-market stock price is 102.50. The pre-market share volume is 1,690.00, and the stock has decreased by -0.50, or -0.49%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.